Peptide having activity to improve skin condition and use thereof
US-10487113-B2 · Nov 26, 2019 · US
Protease inhibitors
Protease inhibitors · Cooperative Patent Classification (CPC)
Chemical and metallurgical processes, compounds, and materials.
Related technology areas
Mapped technology topics for this CPC code.
| Metric | Value |
|---|---|
| CPC code | C07K14/81 |
| Official title | Protease inhibitors |
| Display label | Protease inhibitors |
| Total patents | 169 |
Filing trend
Year-over-year patent counts classified under this CPC code.
Filing activity over the last five years is rapidly declining.
| Year | Patents |
|---|---|
| 2015 | 6 |
| 2016 | 14 |
| 2017 | 9 |
| 2018 | 12 |
| 2019 | 26 |
| 2020 | 22 |
| 2021 | 24 |
| 2022 | 22 |
| 2023 | 17 |
| 2024 | 9 |
| 2025 | 8 |
Representative patents
Representative publications under this CPC code from precomputed stats, or recent filings when stats are unavailable.
Compositions, methods and uses for alpha-1 antitrypsin fusion molecules
US-10478508-B2 · Nov 19, 2019 · US
Methods for subtyping of lung squamous cell carcinoma
US-2019338366-A1 · Nov 7, 2019 · US
Protein biomarkers for immune assessment and prediction of transplant rejection
US-10451636-B2 · Oct 22, 2019 · US
Etanercept Formulations Stabilized with Sodium Chloride
US-2019314499-A1 · Oct 17, 2019 · US
Etanercept Formulations Stabilized with Sodium Chloride
US-2019314498-A1 · Oct 17, 2019 · US
Method of treating atherosclerosis
US-2019309089-A1 · Oct 10, 2019 · US
Stable Aqueous Etanercept Composition
US-2019290766-A1 · Sep 26, 2019 · US
Stable Aqueous Etanercept Composition
US-2019290768-A1 · Sep 26, 2019 · US
Method of Reducing Formation of Etanercept Aggregates or Fragments
US-2019290765-A1 · Sep 26, 2019 · US
Methods and compositions for treating genetic eye diseases
US-2019284544-A1 · Sep 19, 2019 · US
Genetically modified mouse model for human hepatocyte xenotransplantation
US-2019274290-A1 · Sep 12, 2019 · US
Etanercept formulations stabilized with combinations of sugars and polyols
US-10376588-B2 · Aug 13, 2019 · US
Etanercept formulations stabilized with amino acids
US-2019216930-A1 · Jul 18, 2019 · US
Etanercept formulations stabilized with xylitol
US-2019184017-A1 · Jun 20, 2019 · US
Human Antibodies Against Tissue Factor and Methods of Use Thereof
US-2019169311-A1 · Jun 6, 2019 · US
Etanercept formulations stabilized with amino acids
US-10293049-B2 · May 21, 2019 · US
Treatment of ischemia reperfusion injury using alpha-2 macroglobulin
US-2019142899-A1 · May 16, 2019 · US
Etanercept formulations stabilized with xylitol
US-10213508-B2 · Feb 26, 2019 · US
Translatable molecules and synthesis thereof
US-2018327471-A1 · Nov 15, 2018 · US
Frequently asked questions
Answers are generated from the same data shown on this page.
- What is CPC C07K14/81?
- CPC C07K14/81 is the Cooperative Patent Classification code for “Protease inhibitors.”
- How many patents are filed under CPC C07K14/81 (Protease inhibitors)?
- Our database includes 169 publications tagged with this CPC code.
- Is patent activity under CPC C07K14/81 growing?
- Publication counts under this code: 9 in 2024 vs 8 in 2025 (latest complete years).